Kura Oncology Inc (NASDAQ:KURA)

21.06
Delayed Data
As of Sep 17
 +0.88 / +4.36%
Today’s Change
15.12
Today|||52-Week Range
43.00
-35.52%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-22.6M-27.6M-35.4M-60.4M
 
 
 
 
 
Depreciation20.0K31.0K30.0K10.0K
 
 
 
 
 
Total Other Cash Flow3.3M2.3M4.4M7.4M
 
 
 
 
 
Funds From Operations-19.3M-25.3M-31.0M-53.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.4M80.0K-2.6M-4.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-17.9M-25.3M-28.4M-48.7M
 
 
 
 
 
 
InvestingIncrease In Investments-76.6M-56.4M-100.6M-237.4M
 
 
 
 
 
Decrease In Investments6.0M68.6M77.2M158.1M
 
 
 
 
 
Capital Expenditures-64.0K0.000.000.00
 
 
Net Cash Flow Investing-70.6M12.2M-23.4M-79.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--0.000.00--
Long Term Borrowings5.0M7.5M0.00627.0K
 
 
 
 
Long Term Debt Reduction0.00---344.0K-1.3M
 
 
 
Net Proceeds Stock Sale97.9M0.0053.9M133.3M
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.00--0.000.00--
Cash Dividends Paid - Total0.00--0.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing102.9M7.5M53.6M132.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash14.3M-5.7M1.7M4.7M